Search
Estudi d’utilització de medicaments per al tractament de la incontinència urinària: informe d’utilització de medicaments
(2021)
Urinary incontinence (UI) is a symptom of filling that is defined as the involuntary loss of urine produced during the bladder filling phase. Some authors nuance this definition by considering that these losses must be ...
Coronavirus SARS-CoV-2: nota informativa sobre la seguretat dels inhibidors del cotransportador sodi-glucosa tipus 2 (ISGLT2) en el context de la crisi de la COVID-19 [fullet]
(2020-04-15)
Recommendations on ISGLT2 treatment have been published in the context of SARS-CoV-2 coronavirus infection from a single English-language hospital consortium, which have not been assumed by the rest of the British NHS. ...
Lenalidomida per al tractament de manteniment de mieloma múltiple després d'un trasplantament autòleg de cèl·lules mare
(2018-09-27)
Multiple myeloma (MM) is a neoplasm of plasma cells that occupy the bone marrow and can also have an extramedullary expansion. The MM is characterized by the involvement of target organs (hematopoiesis, cortical bone and ...
Inhibidors del cotransportador sodi-glucosa tipus 2 (ISGLT2) i ISGLT2/metformina per al tractament de la diabetis mellitus tipus 2
(2021-03-03)
The term Diabetes Mellitus (DM) defines a series of metabolic disorders characterized by chronic hyperglycemia and disorders in the metabolism of carbohydrates, fats and proteins, as a result of defects in the secretion ...
Naldemedina per al tractament del restrenyiment induït per opioides
(2021-05-19)
Opioids are one of the pillars in the symptomatic treatment of moderate to severe acute pain, especially in postoperative pain, as well as in chronic oncological and non-oncological pain, although in the latter its evidence ...
Tractament farmacològic de la malaltia d’Alzheimer: informe del Registre de Tractament Farmacològic de la Malaltia d’Alzheimer a l’any 2020
(2021-09)
Alzheimer’s disease (AD) is a progressive, irreversible neurodegenerative disorder that is usually slow but sustained over time. AD is the most common cause of dementia (69%). Its prevalence is 5.1% and increases exponentially ...